Archives
Categories
- Adaptive Trials
- Biotech
- Books
- Contract research
- Cost containment
- Drug development
- Electronic data capture
- Europe
- Genomics
- Internet
- Investigators
- IRB
- Medical devices
- News
- Patient care
- Patient recruitment
- Patient safety
- Phase I
- Phase I trials
- Phase II
- Preclinical studies
- Promoting trials
- Site Selection
- Speed to market
- Thought leaders
Subscribe
About us
Medelis is an oncology CRO that provides clinical trial planning, trial management and oncology drug development services. Learn more or contact us today.
Recent posts
- Transforming Oncology Drug Development with Adaptive Trials
- Medelis co-founder Daniel Von Hoff receives prestigious ASCO scientific honor
- Adaptive Trial Design for Phase I, Phase II
- ASU launches new Master of Science, Clinical Research Management program
- Mouse Hematology: A Laboratory Manual
- Dr. Alan Sandler, Dr. James Cassidy Join Medelis' Medical Advisory Board
- Medelis expands CRO services to medical devices, welcomes Dr. Inder Makin
- Big pharma tackles patient recruitment challenges, but we have a long way to go
- IRB Selection Tips from ClinPage
- "Context of vulnerability" and its role in targeted drug development
Posts by Category
- Adaptive Trials
- Biotech
- Books
- Contract research
- Cost containment
- Drug development
- Electronic data capture
- Europe
- Genomics
- Internet
- Investigators
- IRB
- Medical devices
- News
- Patient care
- Patient recruitment
- Patient safety
- Phase I
- Phase I trials
- Phase II
- Preclinical studies
- Promoting trials
- Site Selection
- Speed to market
- Thought leaders
Subscribe
Insider Abstracts
View, download and share our Insider Abstracts via Slideshare, a service that allows you to discover, upload, download and share presentations with colleagues and your community.
Learn about Medelis
Twitter updates
Our CRO Services
